Numerous studies have established that NUDT15 variants are associated with mercaptopurine intolerance in pediatric ALL in different populations, highlighting the importance of preemptive genetic typing in these patients20–30. This evidence concerns the gene NUDT15 and acute lymphoblastic leukemia.